BRPI0814931A2 - Composto com atividade contra hcv, sua composição e seu uso - Google Patents
Composto com atividade contra hcv, sua composição e seu usoInfo
- Publication number
- BRPI0814931A2 BRPI0814931A2 BRPI0814931-3A2A BRPI0814931A BRPI0814931A2 BR PI0814931 A2 BRPI0814931 A2 BR PI0814931A2 BR PI0814931 A BRPI0814931 A BR PI0814931A BR PI0814931 A2 BRPI0814931 A2 BR PI0814931A2
- Authority
- BR
- Brazil
- Prior art keywords
- composite
- composition
- hcv activity
- hcv
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95481407P | 2007-08-09 | 2007-08-09 | |
US4994408P | 2008-05-02 | 2008-05-02 | |
US12/180,994 US7652004B2 (en) | 2007-08-09 | 2008-07-28 | Compounds for the treatment of hepatitis C |
PCT/US2008/071881 WO2009029384A2 (en) | 2007-08-09 | 2008-08-01 | Compounds for the treatment of hepatitis c |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0814931A2 true BRPI0814931A2 (pt) | 2015-02-03 |
Family
ID=40261456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0814931-3A2A BRPI0814931A2 (pt) | 2007-08-09 | 2008-08-01 | Composto com atividade contra hcv, sua composição e seu uso |
Country Status (18)
Country | Link |
---|---|
US (1) | US7652004B2 (pt) |
EP (1) | EP2183252B1 (pt) |
JP (1) | JP5465670B2 (pt) |
KR (1) | KR20100066492A (pt) |
CN (1) | CN101821267B (pt) |
AR (1) | AR067897A1 (pt) |
AU (1) | AU2008293845B2 (pt) |
BR (1) | BRPI0814931A2 (pt) |
CA (1) | CA2695781A1 (pt) |
CL (1) | CL2008002353A1 (pt) |
CO (1) | CO6251359A2 (pt) |
EA (1) | EA015978B1 (pt) |
MX (1) | MX2010001416A (pt) |
NZ (1) | NZ583149A (pt) |
PE (1) | PE20090618A1 (pt) |
TW (1) | TW200906418A (pt) |
WO (1) | WO2009029384A2 (pt) |
ZA (1) | ZA201000923B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005049622A1 (ja) * | 2003-11-19 | 2005-06-02 | Japan Tobacco Inc. | 5-5員縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての用途 |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
US8143243B2 (en) * | 2007-08-09 | 2012-03-27 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
MX2010005226A (es) * | 2007-11-20 | 2010-05-27 | Bristol Myers Squibb Co | Inhibidores de ns5b de hcv de indolobenzazepina fusionados a ciclopropilo. |
US8129367B2 (en) * | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
EP2278977B1 (en) | 2008-03-27 | 2011-11-02 | Bristol-Myers Squibb Company | Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors |
US8133884B2 (en) * | 2008-05-06 | 2012-03-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
EP2396329B1 (en) * | 2009-02-11 | 2014-10-29 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis c |
US9173887B2 (en) | 2010-12-22 | 2015-11-03 | Abbvie Inc. | Hepatitis C inhibitors and uses thereof |
JP5915004B2 (ja) * | 2011-06-22 | 2016-05-11 | セントラル硝子株式会社 | ピラゾール化合物の製造方法 |
CH706864B1 (de) * | 2011-06-22 | 2016-03-31 | Central Glass Co Ltd | Verfahren zur Herstellung einer Pyrazol-Verbindung. |
EA025391B1 (ru) * | 2012-07-18 | 2016-12-30 | Бристол-Майерс Сквибб Холдингс Айеленд | НОВЫЕ СПОСОБЫ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ (4bS,5aR)-12-ЦИКЛОГЕКСИЛ-N-(N,N-ДИМЕТИЛСУЛЬФАМОИЛ)-3-МЕТОКСИ-5a-((1R,5S)-3-МЕТИЛ-3,8-ДИАЗАБИЦИКЛО[3.2.1]ОКТАН-8-КАРБОНИЛ)-4b,5,5a,6-ТЕТРАГИДРОБЕНЗО[3,4]ЦИКЛОПРОПА[5,6]АЗЕПИНО[1,2-a]ИНДОЛ-9-КАРБОКСАМИДА |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1719773T3 (pl) | 2004-02-24 | 2009-08-31 | Japan Tobacco Inc | Skondensowane związki heterotetracykliczne i ich zastosowanie jako inhibitora polimerazy HCV |
US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
WO2006046030A2 (en) | 2004-10-26 | 2006-05-04 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Tetracyclic indole derivatives as antiviral agents |
GB0518390D0 (en) | 2005-09-09 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7473688B2 (en) | 2005-09-13 | 2009-01-06 | Bristol-Myers Squibb Company | Indolobenzazepine HCV NS5B inhibitors |
US7456165B2 (en) * | 2006-02-08 | 2008-11-25 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
GB0608928D0 (en) | 2006-05-08 | 2006-06-14 | Angeletti P Ist Richerche Bio | Therapeutic agents |
US7456166B2 (en) | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521441B2 (en) | 2006-05-22 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521442B2 (en) | 2006-05-25 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
CN101490054B (zh) | 2006-05-25 | 2012-05-16 | 百时美施贵宝公司 | 环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂 |
US7452876B2 (en) | 2006-06-08 | 2008-11-18 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7541351B2 (en) | 2007-01-11 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7517872B2 (en) | 2007-02-22 | 2009-04-14 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7521444B2 (en) | 2007-03-14 | 2009-04-21 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7538102B2 (en) | 2007-03-14 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US7547690B2 (en) | 2007-03-14 | 2009-06-16 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US7541353B2 (en) | 2007-03-14 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7538103B2 (en) | 2007-03-15 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
-
2008
- 2008-07-28 US US12/180,994 patent/US7652004B2/en active Active
- 2008-08-01 NZ NZ583149A patent/NZ583149A/en not_active IP Right Cessation
- 2008-08-01 CN CN2008801108622A patent/CN101821267B/zh not_active Expired - Fee Related
- 2008-08-01 AU AU2008293845A patent/AU2008293845B2/en not_active Ceased
- 2008-08-01 WO PCT/US2008/071881 patent/WO2009029384A2/en active Application Filing
- 2008-08-01 EA EA201000277A patent/EA015978B1/ru not_active IP Right Cessation
- 2008-08-01 KR KR1020107005086A patent/KR20100066492A/ko not_active Application Discontinuation
- 2008-08-01 JP JP2010520215A patent/JP5465670B2/ja not_active Expired - Fee Related
- 2008-08-01 BR BRPI0814931-3A2A patent/BRPI0814931A2/pt not_active IP Right Cessation
- 2008-08-01 CA CA2695781A patent/CA2695781A1/en not_active Abandoned
- 2008-08-01 MX MX2010001416A patent/MX2010001416A/es active IP Right Grant
- 2008-08-01 EP EP08828571.3A patent/EP2183252B1/en not_active Not-in-force
- 2008-08-08 AR ARP080103488A patent/AR067897A1/es unknown
- 2008-08-08 CL CL200802353A patent/CL2008002353A1/es unknown
- 2008-08-08 TW TW097130410A patent/TW200906418A/zh unknown
- 2008-08-08 PE PE2008001327A patent/PE20090618A1/es not_active Application Discontinuation
-
2010
- 2010-02-03 CO CO10011252A patent/CO6251359A2/es not_active Application Discontinuation
- 2010-02-08 ZA ZA2010/00923A patent/ZA201000923B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2183252A2 (en) | 2010-05-12 |
WO2009029384A3 (en) | 2009-05-28 |
NZ583149A (en) | 2011-07-29 |
WO2009029384A2 (en) | 2009-03-05 |
CN101821267B (zh) | 2013-07-10 |
CL2008002353A1 (es) | 2008-10-24 |
TW200906418A (en) | 2009-02-16 |
KR20100066492A (ko) | 2010-06-17 |
EA015978B1 (ru) | 2012-01-30 |
CA2695781A1 (en) | 2009-03-05 |
AR067897A1 (es) | 2009-10-28 |
EA201000277A1 (ru) | 2010-06-30 |
CO6251359A2 (es) | 2011-02-21 |
EP2183252B1 (en) | 2015-01-14 |
MX2010001416A (es) | 2010-03-01 |
CN101821267A (zh) | 2010-09-01 |
JP5465670B2 (ja) | 2014-04-09 |
US7652004B2 (en) | 2010-01-26 |
AU2008293845B2 (en) | 2013-02-14 |
PE20090618A1 (es) | 2009-05-16 |
AU2008293845A1 (en) | 2009-03-05 |
US20090074715A1 (en) | 2009-03-19 |
JP2010535787A (ja) | 2010-11-25 |
ZA201000923B (en) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0814931A2 (pt) | Composto com atividade contra hcv, sua composição e seu uso | |
BRPI0808098A2 (pt) | 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso | |
BRPI0718192A2 (pt) | Corantes dispersos, sua preparação e seu uso. | |
BRPI1011521A2 (pt) | Composto de hidrazida e uso do mesmo no controle de pragas. | |
BRPI0913264A2 (pt) | copoliamida, composição compreendendo tal copoliamida e seu uso | |
BRPI1010957A2 (pt) | variantes de celulase com expressão, atividade e/ou estabilidade aprimorada e uso das mesmas. | |
BRPI0821276A2 (pt) | Produto, e, uso do produto | |
BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
BRPI0918789A2 (pt) | variantes de beta-glicosidase tendo atividade melhorada, e uso das mesmas | |
BRPI0813770A2 (pt) | Composição, e, uso de uma composição | |
BRPI0819299A2 (pt) | Uso de composição, e, composição contendo proteína | |
BRPI0719345A2 (pt) | Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. | |
BRPI0806589A2 (pt) | Catalisador, sua preparação e uso. | |
BRPI0915552A2 (pt) | derivados de ciclosporina, seu uso e sua composição farmacêutica | |
BRPI0808798A2 (pt) | Fenoxifenilamidinas 3,5-dissubstituídas e seu uso como fungicidas | |
BRPI0810654A2 (pt) | Tiadiazoliloxifenilamidinas e o seu uso como fungicidas. | |
BRPI0813263A2 (pt) | Oxazolidinonas substituídas e seu uso | |
BRPI0816372A2 (pt) | Ácidos 6-fenilnicotínicos substituídos e seu uso | |
BRPI0812766A2 (pt) | 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas | |
BRPI0818641A2 (pt) | Rótulo, e, uso do rótulo | |
BRPI0907053A2 (pt) | Poliisobutenoamina, composição combustível, e, uso de poliisobutenoaminas | |
BRPI0921441A2 (pt) | liga de cobre-estanho, material composto e uso | |
BRPI0810323A2 (pt) | "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso" | |
BRPI0909828A2 (pt) | corantes dispersos de azopiridona, sua preparação e uso | |
BRPI0908786A2 (pt) | Composição de material com estrutura porosa, métodos de preparação e usos correspondentes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |